Paying users zone. Data is covered by 
.
Get to Abbott Laboratories for $17.99, or
get to whole website for at least 3 months from $49.99.
Analysis of Operating Leases
Difficulty: Advanced
An operating lease is treated like a rental contract. Neither the leased asset nor the associated liability is reported on the lessee statement of financial position, but the rights may be very similar to the rights of an owner. The lessee only records the lease payments as a rental expense in income statement.
Present Value of Future Operating Lease Payments
Abbott Laboratories, future operating lease payments
1 Source: Abbott Laboratories Annual Reports
2 Weighted-average interest rate for Abbott Laboratories's debt
| Year | Future operating lease payments (as reported)1 | Year | Future operating lease payments (estimated) | Present value at % |
|---|---|---|---|---|
| 2018 | |
2018 | |
|
| 2019 | |
2019 | |
|
| 2020 | |
2020 | |
|
| 2021 | |
2021 | |
|
| 2022 | |
2022 | |
|
| 2023 and thereafter | |
2023 | |
|
| 2024 | |
|
||
| 2025 | |
|
||
| 2026 | |
|
||
| 2027 | |
|
||
| Total: | |
|
|
1 Source: Abbott Laboratories Annual Reports
| Year | Future operating lease payments (as reported)1 | Year | Future operating lease payments (estimated) | Present value at % |
|---|---|---|---|---|
| 2017 | |
2017 | |
|
| 2018 | |
2018 | |
|
| 2019 | |
2019 | |
|
| 2020 | |
2020 | |
|
| 2021 | |
2021 | |
|
| 2022 and thereafter | |
2022 | |
|
| 2023 | |
|
||
| 2024 | |
|
||
| 2025 | |
|
||
| Total: | |
|
|
1 Source: Abbott Laboratories Annual Reports
| Year | Future operating lease payments (as reported)1 | Year | Future operating lease payments (estimated) | Present value at % |
|---|---|---|---|---|
| 2016 | |
2016 | |
|
| 2017 | |
2017 | |
|
| 2018 | |
2018 | |
|
| 2019 | |
2019 | |
|
| 2020 | |
2020 | |
|
| 2021 and thereafter | |
2021 | |
|
| 2022 | |
|
||
| 2023 | |
|
||
| Total: | |
|
|
1 Source: Abbott Laboratories Annual Reports
| Year | Future operating lease payments (as reported)1 | Year | Future operating lease payments (estimated) | Present value at % |
|---|---|---|---|---|
| 2015 | |
2015 | |
|
| 2016 | |
2016 | |
|
| 2017 | |
2017 | |
|
| 2018 | |
2018 | |
|
| 2019 | |
2019 | |
|
| 2020 and thereafter | |
2020 | |
|
| 2021 | |
|
||
| 2022 | |
|
||
| Total: | |
|
|
1 Source: Abbott Laboratories Annual Reports
| Year | Future operating lease payments (as reported)1 | Year | Future operating lease payments (estimated) | Present value at % |
|---|---|---|---|---|
| 2014 | |
2014 | |
|
| 2015 | |
2015 | |
|
| 2016 | |
2016 | |
|
| 2017 | |
2017 | |
|
| 2018 | |
2018 | |
|
| 2019 and thereafter | |
2019 | |
|
| 2020 | |
|
||
| 2021 | |
|
||
| Total: | |
|
|
1 Source: Abbott Laboratories Annual Reports
Analyst Adjustments for Operating Leases
Abbott Laboratories, adjustments to financial data
USD $ in millions
1, 2 Equal to total present value of future operating lease payments. See Details »
Adjusted Ratios for Operating Leases (Summary)
Abbott Laboratories, adjusted ratios
| Ratio | Description | The company |
|---|---|---|
| Adjusted total asset turnover | An activity ratio calculated as total revenue divided by adjusted total assets. | Abbott Laboratories's adjusted total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017. |
| Adjusted debt-to-equity | A solvency ratio calculated as adjusted total debt divided by total shareholders' equity. | Abbott Laboratories's adjusted debt-to-equity deteriorated from 2015 to 2016 but then slightly improved from 2016 to 2017. |
| Adjusted ROA | A profitability ratio calculated as net income divided by adjusted total assets. | Abbott Laboratories's adjusted ROA deteriorated from 2015 to 2016 and from 2016 to 2017. |
Adjusted Total Asset Turnover
2017 Calculations
1 Total asset turnover = Net sales ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Net sales ÷ Adjusted total assets
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Adjusted total asset turnover | An activity ratio calculated as total revenue divided by adjusted total assets. | Abbott Laboratories's adjusted total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017. |
Adjusted Debt to Equity
2017 Calculations
1 Debt to equity = Total debt ÷ Total Abbott shareholders' investment
= ÷ =
2 Adjusted debt to equity = Adjusted total debt ÷ Total Abbott shareholders' investment
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Adjusted debt-to-equity | A solvency ratio calculated as adjusted total debt divided by total shareholders' equity. | Abbott Laboratories's adjusted debt-to-equity deteriorated from 2015 to 2016 but then slightly improved from 2016 to 2017. |
Adjusted Return on Assets (ROA)
2017 Calculations
1 ROA = 100 × Net earnings ÷ Total assets
= 100 × ÷ = %
2 Adjusted ROA = 100 × Net earnings ÷ Adjusted total assets
= 100 × ÷ = %
| Ratio | Description | The company |
|---|---|---|
| Adjusted ROA | A profitability ratio calculated as net income divided by adjusted total assets. | Abbott Laboratories's adjusted ROA deteriorated from 2015 to 2016 and from 2016 to 2017. |
